HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Rocha Selected Research

bemiparin

1/2013Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.
4/2007Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
11/2006Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS study.
3/2003Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Rocha Research Topics

Disease

7Neoplasms (Cancer)
11/2016 - 07/2003
5Venous Thromboembolism
04/2007 - 09/2000
4Venous Thrombosis (Deep-Vein Thrombosis)
09/2004 - 09/2000
2Critical Illness (Critically Ill)
01/2022 - 06/2021
2Hypercapnia
02/2019 - 05/2018
2Hyperplasia
01/2009 - 12/2008
2Hemorrhage
04/2007 - 09/2000
2Thrombocytopenia (Thrombopenia)
04/2007 - 05/2001
2Thrombosis (Thrombus)
09/2004 - 11/2001
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
10/2000 - 07/2000
2Multiple Organ Failure (MODS)
10/2000 - 07/2000
2Acute Kidney Injury (Acute Renal Failure)
10/2000 - 07/2000
1Melanoma (Melanoma, Malignant)
11/2016
1Uveitis
10/2014
1Sarcoidosis (Schaumann Disease)
10/2014
1Starvation
04/2013
1Lung Neoplasms (Lung Cancer)
01/2013
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2013
1Body Weight (Weight, Body)
01/2009
1Calcinosis
06/2006
1Communicable Diseases (Infectious Diseases)
07/2004
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2004
1Glioma (Gliomas)
03/2004
1Lymphoma (Lymphomas)
01/2004
1Hematologic Neoplasms (Hematological Malignancy)
01/2004
1Mental Disorders (Mental Disorder)
07/2003
1Ischemia
11/2001
1Brain Ischemia (Cerebral Ischemia)
11/2001
1Carcinoid Tumor (Carcinoid)
11/2001
1Purpura
05/2001
1Thrombocytopenic Purpura (Thrombopenic Purpura)
05/2001
1Visceral Leishmaniasis (Kala Azar)
01/2001
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2000
1Thrombophilia
10/2000
1Endotoxemia
07/2000

Drug/Important Bio-Agent (IBA)

4bemiparinIBA
01/2013 - 03/2003
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2006 - 09/2000
3AntigensIBA
01/2004 - 10/2000
3Hemostatics (Antihemorrhagics)IBA
10/2000 - 07/2000
2Levonorgestrel (Plan B)FDA LinkGeneric
02/2019 - 05/2018
2Heparin (Liquaemin)FDA LinkGeneric
09/2004 - 09/2000
2von Willebrand FactorIBA
07/2003 - 10/2000
2LithiumIBA
07/2003 - 11/2001
2Monoclonal AntibodiesIBA
05/2001 - 07/2000
2AntithrombinsIBA
01/2001 - 10/2000
1Progesterone CongenersIBA
02/2019
1SolventsIBA
05/2018
1Ethanol (Ethyl Alcohol)IBA
05/2018
1Progestins (Progestagens)IBA
05/2018
1fiscalin CIBA
11/2016
1chevalone CIBA
11/2016
1tryptoquivalineIBA
11/2016
1fiscalin AIBA
11/2016
1Gallium-67IBA
10/2014
1LipidsIBA
04/2013
1AnticoagulantsIBA
01/2013
1Proteins (Proteins, Gene)FDA Link
01/2009
1Adenosine Triphosphatases (ATPase)IBA
12/2008
1CalciumIBA
06/2006
1Alizarin Red SIBA
06/2006
1Vincristine (Oncovin)FDA LinkGeneric
03/2006
1Cancer VaccinesIBA
07/2004
1Neoplasm Antigens (Tumor Antigens)IBA
07/2004
1VaccinesIBA
07/2004
1Filgrastim (Neupogen)FDA Link
03/2004
1Immunoglobulins (Immunoglobulin)IBA
01/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2003
1IntegrinsIBA
07/2003
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2003
1Enoxaparin (Lovenox)FDA LinkGeneric
03/2003
1Factor Xa (Coagulation Factor Xa)IBA
03/2003
1SodiumIBA
03/2003
1Neuroprotective AgentsIBA
11/2001
1Antiphospholipid AntibodiesIBA
11/2001
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2001
1EpitopesIBA
05/2001
1liposomal amphotericin BFDA Link
01/2001
1VitaminsIBA
12/2000
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2000
1AntioxidantsIBA
12/2000
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2000
1Prothrombin (Factor II)IBA
10/2000
1ThrombomodulinIBA
10/2000
1fibrin fragment D (D-dimer)IBA
10/2000
1ThrombinFDA Link
10/2000
1Plasminogen InactivatorsIBA
10/2000
1Plasminogen Activator Inhibitor 1IBA
07/2000
1Plasminogen Activators (Plasminogen Activator)IBA
07/2000
1EndotoxinsIBA
07/2000

Therapy/Procedure

2Artificial Respiration (Mechanical Ventilation)
01/2022 - 06/2021
2Therapeutics
01/2013 - 09/2004
2Drug Therapy (Chemotherapy)
03/2006 - 03/2004
1Chemoradiotherapy
01/2013
1High-Protein Diet
01/2009
1Transplantation
03/2004
1Immunotherapy
01/2004
1Knee Replacement Arthroplasty (Total Knee Replacement)
03/2003
1Subcutaneous Injections
03/2003
1Continuous Renal Replacement Therapy
07/2000
1Renal Replacement Therapy (Therapies, Renal Replacement)
07/2000